Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: A meta-analysis comprising 26,580 subjects

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 1, 2012, Pages 161-174

  Wang, Furu ^a   Fang, Qiaoqiao ^b   Yu, Ningle ^a   Zhao, Deyu ^b   Zhang, Yimei ^a   Wang, Jin ^a   Wang, Quan ^b   Zhou, Xianfeng ^a   Cao, Xingjiang ^a   Fan, Xiangyong ^a  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ACE I D; diabetic nephropathy; DM type; genetic epidemiology; polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; DATA BASE; DATA EXTRACTION; DIABETIC NEPHROPATHY; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; PUBLISHING; RISK;

ADULT; AGED; DIABETIC NEPHROPATHIES; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 84860013546     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311417655     Document Type: Article

References (97)

1. Wang S, Mitu GM and Hirschberg R. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. Nephrol Dial Transplant 2008; 23: 2167-2172. (Pubitemid 351957618)
2. Ritz E, Rychlik I, Locatelli F and Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34: 795-808. (Pubitemid 29521694)
3. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA and Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-232. (Pubitemid 35463925)
4. Hovind P, Rossing P, Tarnow L, Smidt UM and Parving HH. Progression of diabetic nephropathy. Kidney Int 2001; 59: 702-709. (Pubitemid 32157935)
5. Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O and Parving HH. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 2843-2850. (Pubitemid 37305647)
6. Parving HH, Tarnow L and Rossing P. Genetics of diabetic nephropathy. J Am Soc Nephrol 1996; 7: 2509-2517. (Pubitemid 27469556)
7. Borch-Johnsen K, Norgaard K, Hommel E, et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722.
8. Quinn M, Angelico MC, Warram JH and Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945. (Pubitemid 26249113)
9. Strojek K, Grzeszczak W, Morawin E, et al. Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 1997; 51: 1602-1607. (Pubitemid 27239918)
10. Zintzaras E and Stefanidis I. Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 2005; 50: 84-91. (Pubitemid 40468854)
11. Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA and Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 2007; 52: 881-890. (Pubitemid 350112482)
12. Shpichinetsky V, Raz I, Friedlander Y, et al. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr 2000; 130: 2493-2497.
13. Schmidt S and Ritz E. Genetics of the renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens 1997; 6: 146-151. (Pubitemid 27211776)
14. Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 2000; 36: 449-467.
15. Kim S and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52: 11-34. (Pubitemid 30127593)
16. Rudberg S, Aperia A, Freyschuss U and Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990; 33: 470-476. (Pubitemid 20254869)
17. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
18. Crisan D and Carr J. Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn 2000; 2: 105-115.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346. (Pubitemid 20370444)
20. Doria A, Warram JH and Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I - converting enzyme gene. Diabetes 1994; 43: 690-695.
21. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ and Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ 1994; 309: 1608-1612.
22. Dudley CR, Keavney B, Stratton IM, Turner RC and Ratcliffe PJ. U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907-1911.
23. Fujisawa T, Ikegami H, Shen GQ, et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983-985.
24. Mizuiri S, Hemmi H, Inoue A, et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70: 455-459.
25. Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ and Jerums G. Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 1995; 9: 272-276.
26. Schmidt S, Schone N and Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995; 47: 1176-1181.
27. Tarnow L, Cambien F, Rossing P, et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-494.
28. Chowdhury TA, Dronsfield MJ, Kumar S, et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996; 39: 1108-1114. (Pubitemid 26275942)
29. Doi Y, Yoshizumi H, Yoshinari M, et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102. (Pubitemid 26031020)
30. Nakajima S, Baba T and Yajima Y. Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients? Diabetes Care 1996; 19: 1420-1422. (Pubitemid 26418626)
31. Oh TG, Shin CS, Park KS, et al. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients. Korean J Intern Med 1996; 11: 133-137.
32. Ohno T, Kawazu S and Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996; 45: 218-222. (Pubitemid 26102620)
33. Yoshida H, Kuriyama S, Atsumi Y, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657-664. (Pubitemid 26274398)
34. Barnas U, Schmidt A, Illievich A, et al. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 1997; 40: 327-331. (Pubitemid 27096558)
35. Hibberd ML, Millward BA and Demaine AG. The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complications 1997; 11: 2-8. (Pubitemid 27078961)
36. Jeffers BW, Estacio RO, Raynolds MV and Schrier RW. Angiotensin- converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997; 52: 473-477. (Pubitemid 27359591)
37. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 1997; 99: 1585-1595. (Pubitemid 27163809)
38. Ringel J, Beige J, Kunz R, Distler A and Sharma AM. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997; 40: 193-199. (Pubitemid 27060292)
39. Demurov LM, Chistiakov DA, Chugunova LA, et al. Polymorphism of the insertion/deletion type in the angiotensin-converting enzyme gene in normal subjects and among patients with vascular complications. Mol Biol (Mosk) 1997; 31: 59-62. (Pubitemid 127762608)
40. Schmidt S and Ritz E. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Nephrol Dial Transplant 1997; 12(Suppl. 2): 37-41. (Pubitemid 27331303)
41. Gutierrez C, Vendrell J, Pastor R, et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 1997; 46: 976-980.
42. Pfohl M, Frost D, Koch M, et al. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients. Horm Metab Res 1998; 30: 276-280. (Pubitemid 28267202)
43. Freire MB, van Dijk DJ, Erman A, Boner G, Warram JH and Krolewski AS. DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus. Nephrol Dial Transplant 1998; 13: 2553-2558. (Pubitemid 28445868)
44. Grzeszczak W, Zychma MJ, Lacka B and Zukowska-Szczechowska E. Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. J Am Soc Nephrol 1998; 9: 1664-1669.
45. Hanyu O, Hanawa H, Nakagawa O, et al. Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy. Ren Fail 1998; 20: 125-133.
46. Huang XH, Rantalaiho V, Wirta O, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years. Nephron 1998; 80: 17-24. (Pubitemid 28434687)
47. Wu S, Xiang K, Weng Q, et al. Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy. Chin Med J (Engl) 1998; 111: 478-479. (Pubitemid 128515416)
48. Bouhanick B, Gallois Y, Hadjadj S, Boux de Casson F, Limal JM and Marre M. Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care 1999; 22: 618-622. (Pubitemid 29153051)
49. De Cosmo S, Margaglione M, Tassi V, et al. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev 1999; 15: 247-253. (Pubitemid 29454473)
50. Kuramoto N, Iizuka T, Ito H, et al. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. Am J Kidney Dis 1999; 33: 276-281. (Pubitemid 29072228)
51. Miura J, Uchigata Y, Yokoyama H, Omori Y and Iwamoto Y. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1999; 45: 41-49. (Pubitemid 29356123)
52. Vleming LJ, van der Pijl JW, Lemkes HH, et al. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol 1999; 51: 133-140. (Pubitemid 29116414)
53. Wong TY, Chan JC, Poon E and Li PK. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis 1999; 33: 1064-1070. (Pubitemid 29252676)
54. Tomino Y, Makita Y, Shike T, et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 1999; 82: 139-144. (Pubitemid 29263973)
55. Hsieh MC, Lin SR, Hsieh TJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000; 15: 1008-1013.
56. van Ittersum FJ, de Man AM, Thijssen S, et al. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000; 15: 1000-1007. (Pubitemid 30410372)
57. Araz M, Yilmaz N, Gungor K, Okan V, Kepekci Y and Sukru Aynacioglu A. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 2001; 54: 95-104. (Pubitemid 32964680)
58. Azar ST, Zalloua PA, Medlej R and Halabi G. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics. Endocr Res 2001; 27: 99-108. (Pubitemid 32565581)
59. Gohda T, Makita Y, Shike T, et al. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin Nephrol 2001; 56: 475-480. (Pubitemid 33133605)
60. Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M and Nishizawa Y. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 2001; 24: 1653-1660. (Pubitemid 33716465)
61. Viswanathan V, Zhu Y, Bala K, et al. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP 2001; 2: 83-87. (Pubitemid 38963875)
62. Fradin S, Goulet-Salmon B, Chantepie M, et al. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 2002; 28: 27-32. (Pubitemid 34168747)
63. Lee YJ and Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25: 1002-1008. (Pubitemid 41110485)
64. Ha SK, Park HC, Park HS, et al. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. Am J Kidney Dis 2003; 41: 943-949. (Pubitemid 36532128)
65. Hadjadj S, Gallois Y, Alhenc-Gelas F, et al. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabet Med 2003; 20: 677-682. (Pubitemid 36966565)
66. Okuno S, Utsugi T, Ohno T, et al. Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study. J Int Med Res 2003; 31: 290-298. (Pubitemid 37038273)
67. Chang HR, Cheng CH, Shu KH, Chen CH, Lian JD and Wu MY. Study of the polymorphism of angiotensinogen, angiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc 2003; 66: 51-56. (Pubitemid 37265500)
68. Arzu Ergen H, Hatemi H, Agachan B, Camlica H and Isbir T. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med 2004; 36: 345-350. (Pubitemid 39279530)
69. Park HC, Choi SR, Kim BS, et al. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J 2005; 46: 779-787. (Pubitemid 43085180)
70. Canani LH, Costa LA, Crispim D, et al. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes. Diabet Med 2005; 22: 1167-1172.
71. Prasad P, Tiwari AK, Kumar KM, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 2006; 7: 42.
72. Buraczynska M, Ksiazek P, Drop A, Zaluska W, Spasiewicz D and Ksiazek A. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant 2006; 21: 979-983.
73. So WY, Ma RC, Ozaki R, et al. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-interaction with ACE insertion/deletion polymorphism. Kidney Int 2006; 69: 1438-1443.
74. Osawa N, Koya D, Araki S, et al. Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 2007; 52: 143-151. (Pubitemid 46185108)
75. Hadjadj S, Tarnow L, Forsblom C, et al. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol 2007; 18: 1284-1291. (Pubitemid 46536914)
76. Movva S, Alluri RV, Komandur S, et al. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complications 2007; 21: 237-241. (Pubitemid 47002317)
77. Mollsten A, Kockum I, Svensson M, et al. The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. J Diabetes Complications 2008; 22: 377-383.
78. Gallego PH, Shephard N, Bulsara MK, et al. Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus. J Diabetes Complications 2008; 22: 191-198. (Pubitemid 351545846)
79. Eroglu Z, Cetinkalp S, Erdogan M, et al. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. J Diabetes Complications 2008; 22: 186-190. (Pubitemid 351539058)
80. Tien KJ, Hsiao JY, Hsu SC, et al. Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes. Am J Nephrol 2009; 29: 299-308.
81. Ahluwalia TS, Ahuja M, Rai TS, et al. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 2009; 28: 141-150.
82. Jayapalan JJ, Muniandy S and Chan SP. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J Hum Genet 16: 78-86.
83. Zintzaras E and Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008; 61: 634-645. (Pubitemid 351766746)
84. Higgins JP and Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558. (Pubitemid 34746062)
85. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. (Pubitemid 27387172)
86. Begg CB and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
87. Harrison-Bernard LM. The renal renin-angiotensin system. Adv Physiol Educ 2009; 33: 270-274.
88. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
89. Lewis EJ, Hunsicker LG, Bain RP and Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462. (Pubitemid 23335891)
90. Smith CW, Porro EB, Patton JG and Nadal-Ginard B. Scanning from an independently specified branch point defines the 3′ splice site of mammalian introns. Nature 1989; 342: 243-247. (Pubitemid 19283319)
91. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
92. Tarnow L, Gluud C and Parving HH. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 1998; 13: 1125-1130. (Pubitemid 28227184)
93. Kunz R, Bork JP, Fritsche L, Ringel J and Sharma AM. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol 1998; 9: 1653-1663.
94. Ng DP, Tai BC, Koh D, Tan KW and Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005; 48: 1008-1016. (Pubitemid 40767996)
95. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C and Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997; 350: 326-329. (Pubitemid 27351115)
96. Passaro A, Calzoni F, Volpato S, et al. Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med 2003; 254: 264-271. (Pubitemid 37070228)
97. Ma J, Stampfer MJ, Giovannucci E, et al. Methylene-tetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-1102. (Pubitemid 27138608)